On April 23, 2026, reports emerged highlighting a significant change in the Republican Party's approach to drug policy under the Trump administration.
This new direction marks a departure from the long-standing 'Just Say No' campaign, as the administration is actively funding research into psychedelics.
Additionally, there are efforts to reschedule marijuana, indicating a potential reevaluation of its legal classification.